ANIX Anixa Biosciences Inc

P/E --
Forward P/E --
Price/Sales 377.78
Beta 0.597
Div Yield --
Market Cap --

Company Analysis

Latest News

🟒 Anixa Biosciences is trading 6% up in after-hours trading with no confirmed company-specific catalyst

Anixa Biosciences is trading 6.03% up now at $3.69 in after-hours trading after closing at $3.48 on August 28, 2026, with no confirmed company-specific...

🟒 Anixa Biosciences is trading 6.1% up in pre-market β€” no confirmed company-specific catalyst

Anixa Biosciences is trading at $3.82 (+6.11%) after rising before the August 28, 2026 open, with no confirmed company-specific catalyst identified. - Recent...

πŸ”΄ Anixa Biosciences is trading 15.27% down in pre-market; cause unclear

Anixa Biosciences is trading 15.27% down now at $3.05 after falling sharply before the August 28, 2026 open; no confirmed company-specific announcement,...

πŸ”΄ Anixa Biosciences is trading 16.23% down in pre-market with no confirmed company-specific catalyst

Anixa Biosciences is trading 16.23% down at $3.02, with no confirmed company-specific announcement, filing, earnings release, or clinical update explaining the...

πŸ”΄ Anixa Biosciences is trading 7.17% down in after-hours trading with no confirmed company-specific catalyst

Anixa Biosciences is trading 7.17% down now at $3.35 in after-hours trading after closing at $3.60 on August 26, 2026, with no confirmed company-specific...

🟒 Anixa Biosciences is trading 5.37% up in pre-market as broader biotechnology strength lifts the sector

Anixa Biosciences is trading 5.37% up at $3.86 as broader biotechnology strength lifts the sector. - XBI gained 2.06% during the August 25 regular session,...

🟒 Anixa Biosciences is trading 5.4% up in after-hours trading as XBI gained 2.06%

Anixa Biosciences is trading 5.37% up now at $3.86, as broader biotechnology strength lifted the sector on August 25, 2026. - Biotechnology ETF XBI gained...

🟒 Anixa Biosciences is trading 6.35% up today amid broader biotechnology-sector strength

Anixa Biosciences is trading 6.35% up at $3.85, supported primarily by broader biotechnology-sector strength, with XBI up 2.06% during the regular session. -...

🟒 Anixa Biosciences is trading 5% up in pre-market amid broader global risk-on sentiment

Anixa Biosciences is trading at $3.78, up 5.22%, amid broader global risk-on sentiment. - U.S. futures point higher; the Nasdaq Composite is up 0.62%. -...

Anixa's Vaccine Data Sparks a 9% Rally, but Can a Zero-Revenue Biotech Sustain the Momentum to Phase 2?

Anixa's Vaccine Data Sparks a 9% Rally, but Can a Zero-Revenue Biotech Sustain the Momentum to Phase 2?

Shares of Anixa Biosciences surged 9.3% to $3.75 on August 19 after the company repackaged its strongest clinical data ahead of a marquee investor conference,...

🟒 Anixa Biosciences is trading 9.33% up today after positive breast-cancer vaccine Phase 1 results

Anixa Biosciences is trading 9.33% up at $3.75 after positive breast-cancer vaccine Phase 1 results and encouraging ovarian-cancer CAR-T survival...

πŸ”΄ Anixa Biosciences is trading 8.31% down today in pre-market as risk-off sentiment pressures equities

Anixa Biosciences is trading 8.31% down in pre-market at $3.20, amid broader risk-off sentiment. - Closed at $3.49 on August 17, 2026, when it gained 9.75%. -...

🟒 Anixa Biosciences is trading 10.06% up today, with no clear catalyst identified

Anixa Biosciences is trading 10.06% up at $3.50, but no clear company-specific catalyst has been identified for August 17, 2026. - CEO Amit Kumar’s purchase...

🟒 Anixa Biosciences is trading 5.6% up today β€” no clear catalyst identified

Anixa Biosciences is trading 5.6% up now at $3.36, with no clear company-specific catalyst identified for August 17, 2026. - Recent coverage references CEO...

🟒 Anixa Biosciences is trading 6.46% up in after-hours trading with no definitive catalyst identified

Anixa Biosciences is trading at $3.46 (+6.46%) in after-hours trading, with the move appearing speculative or liquidity-driven and no definitive catalyst...

πŸ”΄ Anixa Biosciences is trading 12% down today reversing an unexplained pre-market spike

Anixa Biosciences is trading at $3.00 (12% down) as the stock reverses a sharp, largely unexplained pre-market jump seen on August 03, 2026. β€’ The move...

🟒 Anixa Biosciences is trading 13.7% up today despite no clear company-specific catalyst

Anixa Biosciences is trading at $3.89 (+13.74%) in pre-market following a sharp overnight move with no fresh company-specific announcements identified. β€’ The...

πŸ”΄ Anixa Biosciences is trading 6.1% down today amid biotech sector weakness

Anixa Biosciences is trading 6.1% down at $3.34 today, giving back a portion of its recent rebound as the broader biotech sector faces selling pressure. β€’ The...

🟒 Anixa Biosciences is trading 6.2% up today amid a broader market rebound

Anixa Biosciences is trading 6.2% up at $3.78 in pre-market, appearing to track a broader risk-on sentiment across U.S. equities. β€’ The move extends a modest...

🟒 Anixa Biosciences up 5.8% as CEO boosts stake and stock rebounds from pullback

β€’ Anixa Biosciences' CEO Amit Kumar made recent significant insider purchases, acquiring thousands of shares on July 27 and July 24. β€’ The stock is rebounding...